Related Experiment Video
Updated: May 31, 2026

Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue
Published on: June 14, 2020
Iron status, hepcidin, and CRP in children with endoscopically confirmed adenotonsillar hypertrophy: a controlled
Serhan Keskin1, Nurşen Keskin2
1Department of Otolaryngology, Head and Neck Surgery, Gebze Fatih State Hospital, Gebze, Kocaeli, Turkey. serhankeskin@live.com.
Insights
Adenotonsillar hypertrophy (ATH) in children does not significantly impact iron levels or inflammation markers. Routine iron evaluation is not recommended solely based on ATH, but targeted assessment may be useful for specific clinical signs.
Area of Science:
- Pediatric Health
- Hematology
- Immunology
Background:
- Adenotonsillar hypertrophy (ATH) may affect iron homeostasis and inflammation in children.
- Previous findings on ATH's impact on iron status and inflammation in children are inconsistent.
Purpose of the Study:
- To compare hematologic, iron-related, and inflammatory parameters in children with and without endoscopically confirmed ATH.
- To investigate the association between ATH and iron deficiency, anemia, and inflammation markers.
Main Methods:
- Controlled cross-sectional study of 300 children (6-12 years old): 150 with ATH, 150 controls.
- Measured hemoglobin, serum iron, ferritin, mean corpuscular volume (MCV), C-reactive protein (CRP), and hepcidin.
- Defined iron deficiency and anemia using World Health Organization criteria.
Main Results:
- No statistically significant differences in hemoglobin, iron indices, CRP, or hepcidin between children with and without ATH.
- Iron deficiency prevalence: 30% in ATH group vs. 24% in controls (p=0.24).
- Iron-deficiency anemia prevalence: 10% in ATH group vs. 8% in controls (p=0.55).
Conclusions:
- ATH is not associated with significant differences in routine iron indices, CRP, or hepcidin in this cohort.
- Findings do not support routine iron evaluation solely based on ATH.
- Targeted iron assessment may be considered for children with relevant clinical findings related to ATH.
Background:
Adenotonsillar hypertrophy (ATH) may influence iron homeostasis through low-grade inflammation and upper airway obstruction, but findings in children remain inconsistent. This study aimed to compare hematologic, iron-related, and inflammatory parameters in school-aged children with and without endoscopically confirmed ATH.
Methods:
This controlled cross-sectional study included 300 children aged 6-12 years (150 with ATH and 150 controls). Hemoglobin, serum iron, ferritin, mean corpuscular volume (MCV), C-reactive protein (CRP), and hepcidin were measured. Iron deficiency and anemia were defined according to World Health Organization criteria. Continuous variables were compared using parametric or nonparametric tests as appropriate, and categorical variables were analyzed using Pearson's chi-square test.
Results:
No statistically significant between-group differences were found in hematologic, iron-related, or inflammatory parameters. Iron deficiency was identified in 30% of children with ATH and 24% of controls (p = 0.24), whereas iron-deficiency anemia was present in 10% and 8%, respectively (p = 0.55). CRP and hepcidin levels were also comparable between groups.
Conclusion:
In this outpatient cohort, ATH was not associated with significant differences in routine iron indices, CRP, or hepcidin. These findings do not support routine iron evaluation solely on the basis of ATH, although targeted assessment may be considered in children with relevant clinical findings.
Related Concept Videos
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Tonsillitis II: Management